| (Values in U.S. Thousands) | Dec, 2025 | Dec, 2024 | Dec, 2023 | Dec, 2022 | Aug, 2026 |
| Sales | 8,650 | 8,190 | 6,710 | 23,550 | 0 |
| Sales Growth | +5.62% | +22.06% | -71.51% | unch | unch |
| Net Income | 6,400 | 2,370 | 2,250 | 10,010 | 0 |
| Net Income Growth | +170.04% | +5.33% | -77.52% | unch | unch |
Anbio Biotechnology Cl A (NNNN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Anbio Biotechnology is a diagnostic company dedicated to the advancement of medical technology and the provision of in vitro diagnostics products. Anbio Biotechnology is based in Frankfurt am Main, Germany.
Fiscal Year End Date: 12/31